Funding for this research was provided by:
national health and medical research council (NHMRC Investigator Grant APP1175929)
Received: 14 July 2021
Accepted: 23 September 2021
First Online: 13 October 2021
: Ethics approval was received from the Peter MacCallum Cancer Centre Human Research and Ethics Committee with a consent waiver granted.
: Authors LM/KC/JC/JX/AC/AL have no relevant financial or non-financial interests to disclose.Author DR receives institutional research funding: MSD, Bristol-Myers Squibb, GSK, Roche. Travel – MSD, GSK. Trial Steering Committees and/or Advisory Boards (all uncompensated): MSD, GSK, Regeneron, Sanofi.Author RH is a Co-Editor in Chief of Cancer Imaging and fellow of the International Cancer Imaging Society.